Latest Circulars: (IPC) Indian Pharmacopoeia Commission

Important Notifications / Notices / Circulars by IPC

515
IPC
Representational image

Last Updated on September 20, 2021 by The Health Master

Download Latest Circulars: (IPC) Indian Pharmacopoeia Commission

Download Latest Circulars: (IPC) Indian Pharmacopoeia Commission: Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India. IPC is created to set standards of drugs in the country.

Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region.

It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).

We have provided List of impurities, List of reference substances and important notification, notices and circulars by IPC (Source IPC website. Click below links:

Laboratory
Picture: Pixabay

List of impurities

For List of 145 Impurities Dec 2019, click below link:

List-of-145-Impurities-Dec-2019

List of reference substances

For List of 594-Reference-Substances Dec 2019, click below link:

List-of-594-Reference-Substances-Dec-2019


Important Notifications / Notices / Circulars by IPC

IPC dt 16-09-2021 – Guidance document on Calibration of Gas Chromatograph

IPC-dt-16-09-2021-Guidance-document-on-Calibration-of-Gas-Chromatograph

IPC dt 16-09-2021 – Guidance document on Calibration of HPLC

IPC-dt-16-09-2021-Guidance-document-on-Calibration-of-HPLC

IPC dt 16-09-2021 – Guidance document on Compliance with Indian Pharmacopoeia Standards

IPC-dt-16-09-2021-Guidance-document-on-Compliance-with-Indian-Pharmacopoeia-Standards

IPC dt 16-09-2021 – Guidance document on Good Documentation Practices

IPC-dt-16-09-2021-Guidance-document-on-Good-Documentation-Practices

IPC dt 16-09-2021 – Guidance document on Legal Status of Indian Pharmacopoeia

IPC-dt-16-09-2021-Guidance-document-on-Legal-Status-of-Indian-Pharmacopoeia

IPC dt 16-09-2021 – Guidance document on Process for Development of Indian Pharmacopoeia Monographs

IPC-dt-16-09-2021-Guidance-document-on-Process-for-Development-of-Indian-Pharmacopoeia-Monographs

IPC dt 16-09-2021 – Guidance document on Quality Management System in Testing Laboratory

IPC-dt-16-09-2021-Guidance-document-on-Quality-Management-System-in-Testing-Laboratory

IPC dt 16-09-2021 – Guidance document on Validation of Analytical Methods

IPC-dt-16-09-2021-Guidance-document-on-Validation-of-Analytical-Methods

IPC Notice dt 26-07-2021 – IP Addendum 2021 shall be effective from 31-12-2021

IPC-Notice-dt-26-07-2021-IP-Addendum-2021-shall-be-effective-from-31-12-2021

IPC dt 24-06-21 – Revised Draft General Chapter on Approach to Alternative Microbiological Methods

IPC-dt-24-06-21-Revised-Draft-General-Chapter-on-Approach-to-Alternative-Microbiological-Methods

IPC 10-03-2021 – Omission of Monographs of ‘Lorcaserin Hydrochloride Hemihydrate’ and Lorcaserin Tablets’ from the Indian Pharmacopoeia

IPC-10-03-2021-Omission-of-Monographs-of-Lorcaserin-Hydrochloride-Hemihydrate-and-Lorcaserin-Tablets-from-the-Indian-Pharmacopoeia

IPC dt 26-02-2021 – Clarification on Alternative Methods in the Indian Pharmacopoeia

IPC-dt-26-02-2021-Clarification-on-Alternative-Methods-in-the-Indian-Pharmacopoeia

IPC dt 25-02-2021 – Amendment List-08 to IP-2018

IPC-dt-25-02-2021-Amendment-List-08-to-IP-2018

IPC 19-02-2021 – Release of Guidance Document for Drafting and Formatting of Monographs for Indian Pharmacopoeia

IPC-19-02-2021-Release-of-Guidance-Document-for-Drafting-and-Formatting-of-Monographs-for-Indian-Pharmacopoeia

IPC dt 12-01-2021 – Draft of General Notices on Phytopharmaceutical Drugs

IPC-dt-12-01-2021-Draft-of-General-Notices-on-Phytopharmaceutical-Drugs





Compiled by:
Rakesh DahiyaSDCO cum Licensing Authority, FDA Haryana

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner